Connect with us

Mental health

Older veterans turn to cannabis for mental health issues

Researchers studied cannabis consumption in more than 500 veterans aged 60 and above.

Published

on

Veterans in the study typically reported “desirable health outcomes” as a result of their cannabis use

Older veterans are using cannabis to treat mental health conditions, as well as chronic pain and to improve sleep, says study.

A team of researchers from the University of Illinois studied cannabis consumption in more than 500 veterans aged 60 and above.

Compared to non-veterans of similar ages, those in the study were more likely to report using cannabis for the treatment of mental health conditions, such as post-traumatic stress, anxiety, and insomnia. 

Researchers collected surveys from 514 veterans enrolled in the Illinois Medical Cannabis Patient Programme and examined the use of cannabis, opioids and benzodiazepines compared to non-veterans of a similar age. 

Both groups reported similar levels of ‘pain, quality of life, social satisfaction, and sleep quality’, but veterans were more likely to use cannabis for mental health conditions and non-veterans for pain-relief.

Veterans in the study typically reported “desirable health outcomes” as a result of their cannabis use and were also “less likely” to use opioids and benzodiazepines. 

Most subjects said that cannabis reduced their chronic pain, improved their sleep, and led to improvements in their overall quality of life – a finding that is consistent with prior studies assessing the use of medical cannabis in older populations. 

Authors concluded: “Our work provides insights for clinicians and policy makers to consider whether cannabis can be a viable option to reduce or replace opioid and benzodiazepine use by older veterans with chronic physical and mental health conditions.”

The data was published in The American Journal of Drug and Alcohol Abuse.

Sarah Sinclair is an award-winning freelance journalist covering health, drug policy and social affairs. She is one of the few UK reporters specialising in medical cannabis policy and as the former editor of Cannabis Health has covered developments in the European cannabis sector extensively, with a focus on patients and consumers. She continues to report on cannabis-related health and policy for Forbes, Cannabis Health and Business of Cannabis and has written for The i Paper, Byline Times, The Lead, Positive News, Leafie & others. Sarah has an NCTJ accreditation and an MA in Journalism from the University of Sunderland and has completed additional specialist training through the Medical Cannabis Clinicians Society in the UK. She has spoken at leading industry events such as Cannabis Europa.

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2024 PP Intelligence Ltd.